A firm's worth is measured by the successes of its clients, and we have succeeded because our clients have succeeded. Multi-million dollar licenses have been negotiated. Many FDA approved products are being sold. Internet-based technologies are being used worldwide. Our clients are TRULY MAKING A DIFFERENCE in this world. We celebrate and applaud their successes. It is only by their diligence and efforts that we have been able to continually grow these many years.Clients turn to us, because they want life-changing technologies and robust patents that strategically protect their investments and technologies beyond the ordinary. They want valid and enforceable patents that dramatically increase corporate value, protect platform and product-specific technologies, provide substantial life-cycle extension, are directly tied to key corporate objectives and target commercial products, accurately express scientific principles and technological advancements, and can be touted to and confidently asserted against others. Our clients are prudent with their financial resources and tired of obtaining mediocre patents from large firms charging exorbitant rates. They seek a firm they can trust and rely upon to fully understand and prioritize their interests while providing the highest level of service available.Texas-based Innovar, L.L.C. is a unique one-stop patent and technology consulting service provider for U.S. and foreign corporate, university-based, and individual innovators and investors. We employ a comprehensive approach and integrate patent practice, science, and business to protect technologies and investments and provide clients with the greatest opportunity for commercial success.Rick Matos, Ph.D. is the founder of Innovar, L.L.C. He has over thirty-six years of experience in the pharmaceutical arena as researcher, patent practitioner, and consultant and over thirty years of experience as a patent practitioner. He is an author of scientific articles and is an inventor of pharmaceutical and chemical process technologies. By integrating IP, business and R&D strategies and by building and managing robust large patent portfolios, he has helped client startup corporations raise capital and achieve valuations of tens to hundreds of millions of dollars before being sold or even going public. Many domestic and international pharmaceutical products are covered by patents he has prosecuted.